Literature DB >> 18274928

Genetic and environmental determinants of hepatocyte growth factor levels and their association with obesity and blood pressure.

Yulia Vistoropsky1, Svetlana Trofimov, Ida Malkin, Eugene Kobyliansky, Gregory Livshits.   

Abstract

BACKGROUND: Hepatocyte growth factor (HGF) is a member of the adipocytokine family; it is implicated in tissue repair, regeneration, and angiogenesis. Several studies have reported that the HGF plays important role in obesity and cardiovascular disease. AIM: This study examines whether HGF and its phenotypic correlations with obesity and blood pressure (BP), in healthy individuals, are due to shared genetic or common environmental factors. SUBJECTS AND METHODS: Body mass index (BMI), waist-to-hip ratio (WHR), BP, and HGF plasma concentrations were measured in a sample of 733 individuals belonging to 248 pedigrees.
RESULTS: The most significant phenotypic correlations were found among HGF, WHR, and systolic BP (p < 0.001). Analysis of the familial aggregation revealed that parent-offspring and sibling correlations in HGF levels, adjusted for age, age(2), and sex, were statistically highly significant (p < 0.001). Variance decomposition analysis showed that when adjusted for potential covariates, 48.4% of the HGF variation was due to putative genetic factors. The genetic correlations between all pairs of studied traits (HGF, WHR, and SBP) were statistically significant (p < 0.02) and ranged between 0.23 +/- 0.07 and 0.40 +/- 0.07. However, correlation between WHR and BP becomes non-significant after adjustment for HGF.
CONCLUSIONS: The results provide evidence that putative genetic factors involved in regulation of HGF variation contribute also significantly to variation of the obesity and BP. It is possible that the familial resemblance for WHR and the SBP correlation in the studied sample is affected substantially by genetic factors regulating circulating HGF levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18274928     DOI: 10.1080/03014460701822003

Source DB:  PubMed          Journal:  Ann Hum Biol        ISSN: 0301-4460            Impact factor:   1.533


  10 in total

1.  Trans-ethnic meta-analysis identifies common and rare variants associated with hepatocyte growth factor levels in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Nicholas B Larson; Cecilia Berardi; Paul A Decker; Christina L Wassel; Phillip S Kirsch; James S Pankow; Michele M Sale; Mariza de Andrade; Hugues Sicotte; Weihong Tang; Naomi Q Hanson; Michael Y Tsai; Kent D Taylor; Suzette J Bielinski
Journal:  Ann Hum Genet       Date:  2015-05-22       Impact factor: 1.670

2.  Hepatocyte growth factor and the risk of ischemic stroke developing among postmenopausal women: results from the Women's Health Initiative.

Authors:  Swapnil N Rajpathak; Tao Wang; Sylvia Wassertheil-Smoller; Howard D Strickler; Robert C Kaplan; Aileen P McGinn; Rachel P Wildman; Daniel Rosenbaum; Thomas E Rohan; Philipp E Scherer; Mary Cushman; Gloria Y F Ho
Journal:  Stroke       Date:  2010-03-04       Impact factor: 7.914

3.  Genome-wide association study for endothelial growth factors.

Authors:  Wolfgang Lieb; Ming-Huei Chen; Martin G Larson; Radwan Safa; Alexander Teumer; Sebastian E Baumeister; Honghuang Lin; Holly M Smith; Manja Koch; Roberto Lorbeer; Uwe Völker; Matthias Nauck; Henry Völzke; Henri Wallaschofski; Douglas B Sawyer; Ramachandran S Vasan
Journal:  Circ Cardiovasc Genet       Date:  2014-12-31

4.  Relation of vascular growth factors with CT-derived measures of body fat distribution: the Framingham Heart Study.

Authors:  Bernhard M Kaess; Alison Pedley; Joseph M Massaro; Martin G Larson; Erin Corsini; Udo Hoffmann; Holly M Smith; Douglas B Sawyer; Ramachandran S Vasan; Caroline S Fox
Journal:  J Clin Endocrinol Metab       Date:  2011-12-14       Impact factor: 5.958

5.  Genome-wide identification of copy number variation and association with fat deposition in thin and fat-tailed sheep breeds.

Authors:  Shadan Taghizadeh; Mohsen Gholizadeh; Ghodrat Rahimi-Mianji; Mohammad Hossein Moradi; Roy Costilla; Stephen Moore; Rosalia Di Gerlando
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

Review 6.  The role of miRNAs in polycystic ovary syndrome with insulin resistance.

Authors:  Yingliu Luo; Chenchen Cui; Xiao Han; Qian Wang; Cuilian Zhang
Journal:  J Assist Reprod Genet       Date:  2021-01-06       Impact factor: 3.412

7.  The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples.

Authors:  Sophia Harlid; Robin Myte; Bethany Van Guelpen
Journal:  Mediators Inflamm       Date:  2017-03-22       Impact factor: 4.711

Review 8.  The Role of Hepatocyte Growth Factor (HGF) in Insulin Resistance and Diabetes.

Authors:  Alexandre G Oliveira; Tiago G Araújo; Bruno de Melo Carvalho; Guilherme Z Rocha; Andrey Santos; Mario J A Saad
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-30       Impact factor: 5.555

9.  The aromatase gene (CYP19A1) variants and circulating hepatocyte growth factor in postmenopausal women.

Authors:  Jennifer H Lin; Marc J Gunter; JoAnn E Manson; Kathryn M Rexrode; Nancy R Cook; Peter Kraft; Barbara B Cochrane; Rowan T Chlebowski; Gloria Y F Ho; Shumin M Zhang
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

10.  Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis.

Authors:  T Sathyapalan; R David; N J Gooderham; S L Atkin
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.